Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The nature of a "discussion" board......

Nevertheless, I will continue to post what I consider to be reality, and, whether it is deemed "positive" or "negative", so be it. For instance, although the following will probably be considered "negative" by some, I don't understand how PTSC's performance as a company over the last 4+ years can be deemed to have been a success --- therefore, comments on that subject that aren't offered in praise are simply the natural consequence of that fact. Such comments aren't "bashing", they're just reality.

I do so enjoy reading such eloquence, as above, unfortunately I am unaware of where the performance has in any way been articulated as successful.

The "reality" conveniently has complete disregard to factual and multiple re-examination requests, T3 litigation, and alleged actions of TPL et al. These variables have impacted on PTSC and its performance over the previous four years, the vast majority of which were outwith the control of the BoD, and continue to remain so with the exception of the latter.

Even the "Sage of Omaha" had nineteen of the top 20 stocks in Berkshire fall in value by up to 64%(American Express) - the jury is still out on PDSG with regards to PTSC's investments, but it's my opinion that, as with Buffet, PTSC's investments appeared a good idea at the time.

Any investment has some basis in potential at the time of the investment, and as such some will be realized while others won't. To then bemoan that investment with hindsight is at best disingenuous. As new facts emerge, a review of the decision should be made and actions taken accordingly, not on mere suspicions.

.

.

.

Be well

Share
New Message
Please login to post a reply